Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 3
2004 3
2005 2
2006 7
2007 5
2008 1
2009 5
2010 7
2011 8
2012 3
2013 12
2014 12
2015 9
2016 5
2017 6
2018 9
2019 6
2020 11
2021 28
2022 32
2023 32
2024 29
2025 27
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

248 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial.
Machiels JP, Tao Y, Licitra L, Burtness B, Tahara M, Rischin D, Alves G, Lima IPF, Hughes BGM, Pointreau Y, Aksoy S, Laban S, Greil R, Burian M, Hetnał M, Delord JP, Mesía R, Taberna M, Waldron JN, Simon C, Grégoire V, Harrington KJ, Swaby RF, Zhang Y, Gumuscu B, Bidadi B, Siu LL; KEYNOTE-412 Investigators. Machiels JP, et al. Lancet Oncol. 2024 May;25(5):572-587. doi: 10.1016/S1470-2045(24)00100-1. Epub 2024 Mar 29. Lancet Oncol. 2024. PMID: 38561010 Clinical Trial.
Inflammatory bowel disease genomics, transcriptomics, proteomics and metagenomics meet artificial intelligence.
Cannarozzi AL, Latiano A, Massimino L, Bossa F, Giuliani F, Riva M, Ungaro F, Guerra M, Brina ALD, Biscaglia G, Tavano F, Carparelli S, Fiorino G, Danese S, Perri F, Palmieri O. Cannarozzi AL, et al. Among authors: perri f. United European Gastroenterol J. 2024 Dec;12(10):1461-1480. doi: 10.1002/ueg2.12655. Epub 2024 Aug 31. United European Gastroenterol J. 2024. PMID: 39215755 Free PMC article. Review.
International consensus on laryngeal preservation strategies in laryngeal and hypopharyngeal cancer.
Ferrari M, Mularoni F, Smussi D, Gaudioso P, Bonomo P, Friborg J, Ghi MG, Gregoire V, Harrington K, Hunter K, Maroldi R, Martino R, Mesia R, Peretti G, Psyrri A, Schindler A, Succo G, Szturz P, Vilaseca I, Nicolai P, Bossi P; Consensus Group for Laryngeal Preservation. Ferrari M, et al. Lancet Oncol. 2025 May;26(5):e264-e281. doi: 10.1016/S1470-2045(25)00020-8. Lancet Oncol. 2025. PMID: 40318658 Review.
INTERLINK-1: A Phase III, Randomized, Placebo-Controlled Study of Monalizumab plus Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma.
Fayette J, Licitra L, Harrington K, Haddad R, Siu LL, Liu YC, Tahara M, Machiels JP, Rischin D, Seiwert TY, Ferris RL, Keilholz U, Psyrri A, Keam B, Bossi P, Metcalf R, Hsieh CY, Clement PMJ, Isaev P, Mudunov A, Dinis J, Hoeben A, Kasper S, Klinghammer K, Hwang M, Blando J, Serrano O, Ruscica D, Cohen RB; INTERLINK-1 investigators. Fayette J, et al. Clin Cancer Res. 2025 Jul 1;31(13):2617-2627. doi: 10.1158/1078-0432.CCR-25-0073. Clin Cancer Res. 2025. PMID: 40300079 Free PMC article. Clinical Trial.
Gut virome-colonising Orthohepadnavirus genus is associated with ulcerative colitis pathogenesis and induces intestinal inflammation in vivo.
Massimino L, Palmieri O, Facoetti A, Fuggetta D, Spanò S, Lamparelli LA, D'Alessio S, Cagliani S, Furfaro F, D'Amico F, Zilli A, Fiorino G, Parigi TL, Noviello D, Latiano A, Bossa F, Latiano T, Pirola A, Mologni L, Piazza RG, Abbati D, Perri F, Bonini C, Peyrin-Biroulet L, Malesci A, Jairath V, Danese S, Ungaro F. Massimino L, et al. Among authors: perri f. Gut. 2023 Oct;72(10):1838-1847. doi: 10.1136/gutjnl-2022-328375. Epub 2023 Feb 14. Gut. 2023. PMID: 36788014 Free PMC article.
Potential association between PSCA rs2976395 functional variant and pancreatic cancer risk.
Corradi C, Lencioni G, Felici A, Rizzato C, Gentiluomo M, Ermini S, Archibugi L, Mickevicius A, Lucchesi M, Malecka-Wojciesko E, Basso D, Arcidiacono PG, Petrone MC, Carrara S, Götz M, Bunduc S, Holleczek B, Aoki MN, Uzunoglu FG, Zanette DL, Mambrini A, Jamroziak K, Oliverius M, Lovecek M, Cavestro GM, Milanetto AC, Peduzzi G, Duchonova BM, Izbicki JR, Zalinkevicius R, Hlavac V, van Eijck CHJ, Brenner H, Vanella G, Vokacova K, Soucek P, Tavano F, Perri F, Capurso G, Hussein T, Kiudelis M, Kupcinskas J, Busch OR, Morelli L, Theodoropoulos GE, Testoni SGG, Adamonis K, Neoptolemos JP, Gazouli M, Pasquali C, Kormos Z, Skalicky P, Pezzilli R, Sperti C, Kauffmann E, Büchler MW, Schöttker B, Hegyi P, Capretti G, Lawlor RT, Canzian F, Campa D. Corradi C, et al. Among authors: perri f. Int J Cancer. 2024 Oct 15;155(8):1432-1442. doi: 10.1002/ijc.35046. Epub 2024 Jun 26. Int J Cancer. 2024. PMID: 38924078
Association of a gene-expression subtype to outcome and treatment response in patients with recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab.
Serafini MS, Cavalieri S, Licitra L, Pistore F, Lenoci D, Canevari S, Airoldi M, Cossu Rocca M, Strojan P, Kuhar CG, Merlano M, Perrone F, Vingiani A, Denaro N, Perri F, Argiris A, Gurizzan C, Ghi MG, Cassano A, Allegrini G, Bossi P, De Cecco L. Serafini MS, et al. Among authors: perri f. J Immunother Cancer. 2024 Jan 30;12(1):e007823. doi: 10.1136/jitc-2023-007823. J Immunother Cancer. 2024. PMID: 38290766 Free PMC article. Clinical Trial.
Clinical and genetic drivers of oligo-metastatic disease in colon cancer.
Ottaiano A, Santorsola M, Sirica R, Mauro AD, Di Carlo A, Ianniello M, Sabbatino F, Castiello R, Peschio FD, Cascella M, Perri F, Capuozzo M, Martucci N, Mercadante E, Borzillo V, Di Franco R, Izzo F, Granata V, Picone C, Petrillo A, Berretta M, Stilo S, Tarotto L, Carratù AC, Ferrara G, Tathode M, Cossu AM, Bocchetti M, Caraglia M, Nasti G, Savarese G. Ottaiano A, et al. Among authors: perri f. Neoplasia. 2025 Feb;60:101111. doi: 10.1016/j.neo.2024.101111. Epub 2024 Dec 21. Neoplasia. 2025. PMID: 39709701 Free PMC article.
Development and validation of a risk score for incomplete resection during endoscopic papillectomy: PANETH score.
Binda C, Facciorusso A, Fabbri S, Mutignani M, Tringali A, Di Mitri R, Fugazza A, Sassatelli R, Gabbrielli A, Arcidiacono PG, Di Matteo FM, Coluccio C, Di Marco M, Spada C, Fantin A, De Angelis C, Macchiarelli R, Perri F, Manno M, Cugia L, Mussetto A, Repici A, Tarantino I, Anderloni A, Fabbri C; i‐EUS group. Binda C, et al. Among authors: perri f. Dig Endosc. 2025 Jul;37(7):749-757. doi: 10.1111/den.15005. Epub 2025 Mar 21. Dig Endosc. 2025. PMID: 40114644
The evolving landscape in advanced penile cancer.
Buonerba C, Di Lorenzo G, Calderoni G, Ferro M, Perri F, Lombardi L, Ardito R, Federico P, Placido S, Aieta M. Buonerba C, et al. Among authors: perri f. Future Sci OA. 2015 Nov 1;1(3):FSO9. doi: 10.4155/fso.15.7. eCollection 2015 Nov. Future Sci OA. 2015. PMID: 28031884 Free PMC article. No abstract available.
248 results